精密心脏病学:整合基因疗法,基因组编辑和单细胞基因组学
1Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Journal of cardiology
|September 19, 2025
概括
基因疗法正在通过纠正心脏病的源头来推进心血管医学. 基因编辑和传递领域的新兴技术有望为心脏病提供更精确和潜在的治愈治疗方法.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 基因疗法通过向分子原因提供了治疗心血管疾病的潜力.
- 过去的基因疗法方法面临着挑战,特别是在复杂的心脏病的载体传递方面.
研究的目的:
- 审查基因治疗在心血管医学中的演变.
- 突出新兴基因疗法技术的进展和未来潜力.
主要方法:
- 对基因添加和沉默策略的评估.
- 讨论交付平台 (例如,AAV,脂质纳米粒子) 的进展.
- 检查基因编辑技术 (例如,CRISPR-Cas9,基因编辑器,主要编辑器) 和单细胞基因组学.
主要成果:
- 基因疗法对单一性心肌病有希望,但在多因子心力衰竭方面面临挫折.
- 改进的载体输送系统提高了心脏特异性和安全性.
- 基因编辑可以精确纠正引起疾病的突变.
- 单细胞基因组学揭示了新的细胞特异性治疗点.
结论:
- 基因组学,基因编辑和向传递的融合正在建立精确心脏病学的新时代.
- 这种协同作用将重点从慢性治疗转移到持久的,治愈性心血管干预.
更多相关视频
相关概念视频
00:59Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K